A Reflection on 2023 – Key Takeaways
As we look toward a promising 2024, the ADVI Health team reflected on the biggest issues, regulations, and milestones that helped shape our healthcare landscape this year. From the Inflation Reduction Act (IRA) to a tremendous surge in growth and innovation, demand for data-informed insights, and increasingly more complex paths to market access, there is much to look back on from 2023.
We asked the ADVI team, “As you reflect on our critical work with clients across the healthcare landscape, what is the first key phrase or keyword that comes to mind?” Here’s what they shared.
Learn More
Stay ahead of the curve as you look toward 2024. Get in touch today to gain expert insights and strategic counsel on the evolving healthcare landscape.
CEO insights
Related articles
Real analysis from people who’ve been there
ADVI Health Accelerates Insights with Monthly Medicare Data
ADVI Health now has access to 100% of Medicare Parts A, B, and D research files with monthly availability – …
Why Clinical Laboratories Should Consider Weighing In on CMS and CDC’s New CLIA Request for Information
An opportunity for laboratories to help shape the future of CLIA regulation On July 16, 2026, the Centers for Medicare …
RAND/UCLA Modified Delphi Panels
ADVI Health partners with pharmaceutical and biotech organizations to advance their evidence generation and market access strategies. We support complex research questions through primary research (e.g., …
Caitlin Sheetz, MPH
June 23, 2026
The MolDX Technical Assessment: How to Move Your Test from “Not Successful” to Medicare Coverage Success
In the laboratory space, the MolDX Technical Assessment (TA) is often the moment where the gap between “a great test” …
CRUSH and Genetic and Molecular Laboratories: A Potential Shift in Medicare Oversight
Genetic, molecular, and reference laboratories are closely watching a new Medicare concept known as CRUSH- short for Comprehensive Regulations to …
March Is Colorectal Cancer Awareness Month: Why CMS’s Proposed NCD 210.3 Update Could Accelerate Patient‑Centered Screening Access
Colorectal cancer (CRC) screening saves lives, but only when patients are able to access care in a way that meets …
The 2026 Rare Disease Reality
Orphan drugs now represent approximately 20 percent of total prescription spend, and over 52 percent of the cell and gene …
Marc Samuels, JD, MPH
February 26, 2026
A New Era for Cancer Detection Begins with the Sewell MCED Law
We are seeing a long‑anticipated and important policy inflection point. By now you might have heard that Congress passed the …
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.